Live Status Check

NCT06965621 Recruiting Status

Real-time enrollment status for this heart failure clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 1:04 PM UTC

NCT06965621 Status Summary

NCT NumberNCT06965621
Recruiting StatusRecruiting
ConditionHeart Failure
PhaseClinical Trial
Target Enrollment20 participants
Active Locations1 sites in the US
SponsorInnervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Last Updated on CT.govJuly 1, 2026 (1 week ago)

About NCT06965621 Enrollment Status

As of July 13, 2026: Clinical trial NCT06965621 is currently recruiting participants. This clinical trial study for heart failure is actively seeking new participants at 1 location across the United States. The study is sponsored by Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC). This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06965621

Is NCT06965621 still recruiting?

Yes, NCT06965621 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06965621 recruiting?

This trial is recruiting at 1 location in the United States. View all available locations on the full study page.

How do I enroll in NCT06965621?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06965621 status last updated?

The official ClinicalTrials.gov record for NCT06965621 was last updated 1 week ago (July 1, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial